Azithromycin treatment modulates cytokine production in Chlamydia trachomatis infected women.
Srivastava
Pragya
P
Institute of Pathology, ICMR, Safdarjung Hospital Campus, New Delhi, India.
Jha
Hem Chandra
HC
Salhan
Sudha
S
Mittal
Aruna
A
D000328:Adult; D000900:Anti-Bacterial Agents / Q000494:pharmacology* / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000494:pharmacology* / Q000627:therapeutic use; D017963:Azithromycin / Q000494:pharmacology* / Q000627:therapeutic use; D002690:Chlamydia Infections / Q000150:complications / Q000188:drug therapy* / Q000276:immunology; D002692:Chlamydia trachomatis; D016207:Cytokines / Q000037:antagonists & inhibitors*; D005260:Female; D006801:Humans; D007247:Infertility, Female / Q000209:etiology; D007371:Interferon-gamma / Q000037:antagonists & inhibitors; D007378:Interleukins / Q000037:antagonists & inhibitors; D008875:Middle Aged; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors; D014626:Vaginal Smears
D000900:Anti-Bacterial Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D016207:Cytokines; D007378:Interleukins; D014409:Tumor Necrosis Factor-alpha; D007371:Interferon-gamma; D017963:Azithromycin